Vir Biotech gets U.S. funding for flu-prevention antibody

Go back to Vir Biotech gets U.S. funding for flu-prevention antibody
(NASDAQ: VIR) Delayed: 9.78 +0.57 (6.19%)
Previous Close $9.21    52 Week High
Open $9.31    52 Week Low
Day High $9.86    P/E N/A 
Day Low $9.31    EPS
Volume 1,756,470